Patents-Review.com
ClassID:

96473 ⎘

C07J1/0096 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane; Estrane derivatives; Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group Alkynyl derivatives

Recent Application in this class:
#1
20240124515
2024-04-18

ORALLY ACTIVE LEUKEMIA INHIBITORY FACTOR (LIF) ANTAGONISTS FOR THE TREATMENT OF CANCER

 #2
20230227492
2023-07-20

MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME

 #3
20210379084
2021-12-09

INHIBITORS OF GLUCOCORTICOID RECEPTOR

 #4
20210269474
2021-09-02

Intermediates for the preparation of 11-methylene steroids

 #5
20210023095
2021-01-28

Inhibitors of glucocorticoid receptor

 #6
20210002324
2021-01-07

Inhibitors of glucocorticoid receptor

 #7
20190255076
2019-08-22

SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMMORHAGES

 #8
20190153018
2019-05-23

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

 #9
20190092807
2019-03-28

Process and new intermediates for the preparation of 11-methylene steroids

 #10
20180155386
2018-06-07

PROGESTERONE ANTAGONISTS

 #11
20180064731
2018-03-08

Small molecule therapeutic compounds that reduce the incidence of intracerebral hemorrhage and brain microhemorrhages

 #12
20170088563
2017-03-30

Base-catalyzed silylation of terminal alkyne C—H bonds

 #13
20160279145
2016-09-29

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

 #14
20160060278
2016-03-03

Base-catalyzed silylation of terminal alkyne C—H bonds

 #15
20150031875
2015-01-29

Combined synthesis route for desogestrel and etonogestrel

 #16
20130029953
2013-01-31

PROGESTERONE ANTAGONISTS

 #17
20110306662
2011-12-15

Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer

 #18
20100204497
2010-08-12

Process For The Preparation of 7 alpha-Methylsteroids

 #19
20100035796
2010-02-11

17-alpha-substituted derivatives of estradiol with wound-healing activity

 #20
20100029603
2010-02-04

16ALPHA-METHYL OR ETHYL SUBSTITUTED ESTROGENS

 #21
20070015740
2007-01-18

Derivative prodrugs of ethinyl estradiol

 #22
20060183727
2006-08-17

Estrogenic compounds as anti-mitotic agents

 #23
20060079576
2006-04-13

Estrogenic compounds as anti-mitotic agents

 #24
20050245496
2005-11-03

High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one

 #25
20050222113
2005-10-06

Etonogestrel esters

 #26
20050159609
2005-07-21

Di-steroidal prodrugs of ethinyl estradiol

 #27
20050090476
2005-04-28

Process for the preparation of 7alpha-methylsteroids

 #28
20050020555
2005-01-27

Estrogenic compounds as anti-mitotic agents